Phase I/II trial of IDEC-Y2B8 radioimmunotherapy for treatment of relapsed or refractory CD20 + B-cell non-Hodgkin's lymphoma, J Clin Oncol, vol.17, pp.3793-3803, 1999. ,
General overview of radioimmunotherapy of solid tumors, Immunotherapy, vol.5, pp.467-487, 2013. ,
Pretargeted imaging and therapy, J Nucl Med, vol.58, pp.1553-1559, 2017. ,
Investigations of avidin and biotin for imaging applications, J Nucl Med, vol.28, pp.1294-1302, 1987. ,
Pre-targeted immunoscintigraphy of murine tumors with indium-111-labeled bifunctional haptens, J Nucl Med, vol.29, pp.226-234, 1988. ,
Diagnosis of persistent ovarian carcinoma with three-step immunoscintigraphy, Br J Cancer, vol.82, pp.616-620, 2000. ,
Radioimmunotherapy: from current clinical success to future industrial breakthrough?, J Nucl Med, vol.57, pp.329-331, 2016. ,
Morpholino and phosphorothioate antisense oligomers compared in cell-free and in-cell systems, Antisense Nucleic Acid Drug Dev, vol.7, pp.63-70, 1997. ,
90Y labeled phosphorodiamidate morpholino oligomer for pretargeting radiotherapy, Bioconjug Chem, vol.22, pp.2539-2545, 2011. ,
In vivo hybridization of technetium-99m-labeled peptide nucleic acid (PNA), J Nucl Med, vol.38, pp.907-913, 1997. ,
Tetrazine ligation: fast bioconjugation based on inverse-electron-demand Diels?Alder reactivity, J Am Chem Soc, vol.130, pp.13518-13519, 2008. ,
Highly reactive trans cyclooctene tags with improved stability for DielsAlder chemistry in living systems, Bioconjug Chem, vol.24, pp.1210-1217, 2013. ,
Conformationally strained trans-cyclooctene with improved stability and excellent reactivity in tetrazine ligation, Chem Sci, vol.5, pp.3770-3776, 2014. ,
In vivo chemistry for pretargeted tumor imaging in live mice, Angew Chem Int Ed Engl, vol.49, pp.3375-3378, 2010. ,
Trans-cyclooctene tag with improved properties for tumor pretargeting with the Diels-Alder reaction, Mol Pharm, vol.11, pp.3090-3096, 2014. ,
Pretargeted immuno-PET of pancreatic cancer: overcoming circulating antigen and internalized antibody to reduce radiation doses, J Nucl Med, vol.57, pp.453-459, 2016. ,
Establishment of the in vivo efficacy of pretargeted radioimmunotherapy utilizing inverse electron demand Diels-Alder click chemistry, Mol Cancer Ther, vol.16, pp.124-133, 2017. ,
Click-mediated pretargeted radioimmunotherapy of colorectal carcinoma, Mol Pharm, vol.15, pp.1729-1734, 2018. ,
, Peritoneal carcinomatosis. World J Gastroenterol, vol.19, pp.6979-6994, 2013.
, Colorectal cancer. Nat Rev Dis Primers, vol.1, p.15065, 2015.
Peritoneal carcinomatosis of colorectal cancer: novel clinical and molecular outcomes, Am J Surg, vol.213, pp.377-387, 2017. ,
Applications of hyperthermic intraperitoneal chemotherapy for metastatic colorectal cancer, Expert Rev Anticancer Ther, vol.17, pp.841-850, 2017. ,
Regimens of intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer, Anticancer Res, vol.38, pp.15-22, 2018. ,
Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis, Semin Surg Oncol, vol.14, pp.254-261, 1998. ,
8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer, Ann Surg Oncol, vol.15, pp.2426-2432, 2008. ,
Patterns of recurrence following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer: Recurrence Following HIPEC, J Surg Oncol, vol.109, pp.841-847, 2014. ,
Adjuvant radioimmunotherapy trial with iodine-131-labeled anti-carcinoembryonic antigen monoclonal antibody F6 F(ab')2 after resection of liver metastases from colorectal cancer, Clin Cancer Res, vol.14, pp.3487-3493, 2008. ,
URL : https://hal.archives-ouvertes.fr/inserm-00292535
Fractionated radioimmunotherapy with 90Y-labeled fully human anti-CEA antibody, Cancer Biother Radiopharm, vol.29, pp.70-76, 2014. ,
A comparison between radioimmunotherapy and hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis of colonic origin in rats, Ann Surg Oncol, vol.14, pp.3274-3282, 2007. ,
Experimental study of radioimmunotherapy versus chemotherapy for colorectal cancer, Br J Surg, vol.98, pp.436-441, 2011. ,
Brief intraperitoneal radioimmunotherapy of small peritoneal carcinomatosis using high activities of noninternalizing 125I-labeled monoclonal antibodies, J Nucl Med, vol.51, pp.1748-1755, 2010. ,
URL : https://hal.archives-ouvertes.fr/inserm-00531603
Radiolabeled antibodies against müllerian-inhibiting substance receptor, type II: new tools for a theranostic approach in ovarian cancer, J Nucl Med, vol.59, pp.1234-1242, 2018. ,
Comparison between internalizing anti-HER2 mAbs and non-internalizing anti-CEA mAbs in alpha-radioimmunotherapy of small volume peritoneal carcinomatosis using 212Pb, Plos One, vol.8, p.69613, 2013. ,
Blood CEA levels for detecting recurrent colorectal cancer, Cochrane Database Syst Rev, vol.12, p.11134, 2015. ,
Patient selection for cytoreductive surgery in colorectal peritoneal carcinomatosis using serum tumor markers: an observational cohort study, Ann Surg, vol.256, pp.1078-1083, 2012. ,
Noninternalizing monoclonal antibodies are suitable candidates for 125I radioimmunotherapy of small-volume peritoneal carcinomatosis, J Nucl Med, vol.50, pp.2033-2041, 2009. ,
URL : https://hal.archives-ouvertes.fr/inserm-00442929
Antibody PEGylation in bioorthogonal pretargeting with trans-cyclooctene/tetrazine cycloaddition: in vitro and in vivo evaluation in colorectal cancer models, Sci Rep, vol.7, p.14918, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01646770
MIRD pamphlet No. 21: a generalized schema for radiopharmaceutical dosimetry-standardization of nomenclature, J Nucl Med, vol.50, pp.477-484, 2009. ,
GATE: a simulation toolkit for PET and SPECT, Phys Med Biol, vol.49, pp.4543-4561, 2004. ,
URL : https://hal.archives-ouvertes.fr/in2p3-00021834
GATE V6: a major enhancement of the GATE simulation platform enabling modelling of CT and radiotherapy, Phys Med Biol, vol.56, pp.881-901, 2011. ,
URL : https://hal.archives-ouvertes.fr/in2p3-00559709
A review of the use and potential of the GATE Monte Carlo simulation code for radiation therapy and dosimetry applications, Med Phys, vol.41, p.64301, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01015819
Tetraspanin 8 (TSPAN 8) as a potential target for radio-immunotherapy of colorectal cancer, Oncotarget, vol.8, pp.22034-22047, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01611133
Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery for peritoneal carcinomatosis in an experimental model, Br J Surg, vol.97, pp.1874-1880, 2010. ,
Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: a single-centre feasibility study, Lancet Gastroenterol Hepatol, vol.1, pp.283-290, 2016. ,
Pretargeting in nuclear imaging and radionuclide therapy: improving efficacy of theranostics and nanomedicines, Biomaterials, vol.179, pp.209-245, 2018. ,
How PEGylation influences protein conformational stability, Curr Opin Chem Biol, vol.34, pp.88-94, 2016. ,
Effects of pharmaceutical PEGylation on drug metabolism and its clinical concerns, Expert Opin Drug Metab Toxicol, vol.10, pp.1691-1702, 2014. ,
DOTA-tetrazine probes with modified linkers for tumor pretargeting, Nucl Med Biol, vol.55, pp.19-26, 2017. ,
Tetrazines in inverse-electron-demand Diels-Alder cycloadditions and their use in biology, Synthesis, vol.49, pp.830-848, 2016. ,
Diels-Alder reaction for tumor pretargeting: in vivo chemistry can boost tumor radiation dose compared with directly labeled antibody, J Nucl Med, vol.54, pp.1989-1995, 2013. ,